Your browser doesn't support javascript.
loading
Study design criteria for regulatory-based drug control action: Drug discrimination.
Gauvin, David V; Zimmermann, Zachary J.
Affiliation
  • Gauvin DV; Neurobehavioral Sciences Department, Drug Safety Assessment, Charles River Laboratories, Inc., USA. Electronic address: david.gauvin@crl.com.
  • Zimmermann ZJ; Neurobehavioral Sciences Department, Drug Safety Assessment, Charles River Laboratories, Inc., USA.
J Pharmacol Toxicol Methods ; 111: 107073, 2021.
Article in En | MEDLINE | ID: mdl-33965568
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmaceutical Preparations / Substance-Related Disorders Type of study: Guideline / Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Country/Region as subject: America do norte Language: En Journal: J Pharmacol Toxicol Methods Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2021 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmaceutical Preparations / Substance-Related Disorders Type of study: Guideline / Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Country/Region as subject: America do norte Language: En Journal: J Pharmacol Toxicol Methods Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2021 Document type: Article Country of publication: Estados Unidos